Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Steven A. Gould
|
| gptkbp:closed |
failed clinical trials
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:defunct |
2009
|
| gptkbp:founded |
1985
|
| gptkbp:founder |
Steven A. Gould
|
| gptkbp:headquarters_location |
gptkb:Evanston,_Illinois,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Northfield Laboratories
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:PolyHeme
|
| gptkbp:productType |
artificial blood substitute
|
| gptkbp:stockSymbol |
NFLD
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:PolyHeme
|
| gptkbp:bfsLayer |
8
|